Company intelligence
Cohance Lifesciences
Collaborate. Enhance. Deliver.
About Cohance Lifesciences
Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) is an integrated, technology-driven global CDMO platform committed to advancing therapeutics for a healthier world. Our rebranding from Suven Pharma to Cohance marks a bold new chapter—one that reflects our expanded vision and sharpened focus on collaboration and innovation. The name Cohance captures our purpose: to Collaborate with global innovators and Enhance their molecules, helping bring transformative solutions to patients and consumers worldwide. www.cohance.com
Verified activity
Signals from Cohance Lifesciences
4 published signals
Presence & Recognition
Cohance Lifesciences is attending the CPHI Milan 2026 conference in Milan from October 6 to 8, 2026, with a stand number of 6C39.
Reported by Cohance Lifesciences
People
Cohance Lifesciences welcomed Krishna Sai T as the Chief Information Officer (CIO).
Reported by Cohance Lifesciences
Strategy & Corporate Development
Cohance Lifesciences published its Integrated Annual Report FY2025-26, reflecting the capabilities and institution building.
Reported by Cohance Lifesciences
People
Cohance Lifesciences conducted an immersive Industrial Hygiene Training Program focusing on advancing workplace health and safety, bringing together Site Heads, EHS leaders, Engineering Heads, and key stakeholders.
Reported by Cohance Lifesciences